![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United Kingdom | Publication | February 2023
The DWP, FCA, and the Regulator have published a joint consultation seeking views on proposals for all trustees and administrators running DC schemes to assess and compare their value for money. The paper sets out the proposed standards and a step-by-step process for measuring VFM. Relevant schemes will be required to gather data on investment performance, costs and charges and quality of services. Data on these three factors would then be reported on a standard template, which forms part of the consultation. The consultation sets out how changes would be phased in, initially applying to auto-enrolment default arrangements and legacy DC schemes which have received past employer contributions.
The consultation closes on March 27, 2023, and will be followed by further consultations from the FCA and DWP.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Over the past two years, Spain has significantly strengthened its foreign investment screening mechanism, and all acquisitions by foreign investors (as defined below) of a Spanish entity active in a strategic sector are subject to prior authorisation by the Ministry of Industry, Commerce and Tourism (“MoICT”).
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023